|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
5 February 2024 |
|
Main ID: |
ChiCTR-TNRC-11001489 |
|
Date of registration:
|
2015-07-19 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Risk factors and intervention for cardiology, cerebrovascular and related disease (Kailuan Study)
|
|
Scientific title:
|
Risk factors and intervention for cardiology, cerebrovascular and related disease |
|
Date of first enrolment:
|
2006-01-01 |
|
Target sample size:
|
Observational group:101510; |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://www.chictr.org.cn/showproj.html?proj=8050 |
|
Study type:
|
Observational study |
|
Study design:
|
Sequential
|
|
Phase:
|
0
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Shouling Wu
|
|
Address:
|
57 Xinhua Road East, Tangshan, Hebei, China
063000
|
|
Telephone:
|
+86 315 3025655 |
|
Email:
|
drwusl@163.com |
|
Affiliation:
|
Kailuan Group Co., Ltd. Hospital/Kailuan General Hospital |
|
|
Name:
|
Shouling Wu
|
|
Address:
|
57 Xinhua Road East, Tangshan, Hebei, China
063000
|
|
Telephone:
|
+86 315 3025655 |
|
Email:
|
drwusl@163.com |
|
Affiliation:
|
Kailuan Group Co., Ltd. Hospital/Kailuan General Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Individual aged 18 years and above;
2. Participated in health examination sponsored by Kailuan (Group) Co., Ltd. from June 2006 to September 2007;
3. With completed baseline data.
Exclusion criteria: 1. Baseline data missing;
2. Patients with severe disease and can not be followed up;
3. Those who have already experienced outcome events before the study will be excluded.
Age minimum:
18
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
CVD, Parkinson, Dementia, Renal disorders, Sleep disorders, Diabetes, Autoimmune diseases, Taste/olfactory disorder, Cancer, Liver disease and respiratory disease
|
|
Intervention(s)
|
|
Observational group:None;
|
|
Primary Outcome(s)
|
|
Cardiovascular diseases, cerebrovas diseases;
|
|
Secondary Outcome(s)
|
|
Blood pressure ;Blood glucose;Llipid profiles ;Obesity;Inflammatory markers, such as hypersensitive C-reactive protein, neutrophil / lymphocyte ratio, etc.;Albumin;Iron-related biomarkers ;Arterial stiffness ;Other non-communicable disease markers (e.g. ankle-brachial index);Fundus diseases ;Dietary habit;Brain Structure;Height ;Weight ;Neck circumference;Waist circumference ;Erythrocyte ;Leukocyte;Hemoglobin;Bilirubin;Urea;Creatinine;Uric acid;Urinary protein ;Age ;Gender;Race;Marital status;Education level ;Economic level ;Psychosocial factors;Mental condition;Cognitive level testing;Lifestyle, including sleep duration and quality, smoking, drinking, diet, physical exercise, etc.;Personal history and disease history include cardiovascular and cerebrovascular diseases, hypertension, hyperlipidemia, diabetes, obesity, etc.;Emerging malignant tumor events ;Chronic kidney disease;Fragility fracture event;Mortality;Cerebral small vessel disease;Antihypertensive drugs, hypoglycemic drugs, lipid-lowering drugs and other chronic disease drugs;Nonalcoholic fatty liver;The exposure of Famine in China;The exposure of the Tangshan earthquake;
|
|
Source(s) of Monetary Support
|
|
Kailuan (Group) Co., Ltd.
|
|
Ethics review
|
Status: Approved
Approval date: 05/01/2006
Contact:
Wu Shouling
+86 315 3025655
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|